zDHHC4 is involved in mediating the palmitoylation of GSK3β, which contributes to the promotion of tumorigenicity in temozolomide-resistant glioblastoma stem cells. This effect is achieved through the EZH2-STAT3 axis. This evidence concerns the gene EZH2 and glioblastoma.